Elbasvir/grazoprevir and sofosbuvir for hepatitis C virus genotype 3 infection with compensated cirrhosis: A randomized trial
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Elbasvir/grazoprevir and sofosbuvir for hepatitis C virus genotype 3 infection with compensated cirrhosis: A randomized trial
Authors
Keywords
-
Journal
HEPATOLOGY
Volume 67, Issue 6, Pages 2113-2126
Publisher
Wiley
Online
2018-02-24
DOI
10.1002/hep.29852
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial
- (2018) David Wyles et al. HEPATOLOGY
- Effectiveness of Elbasvir and Grazoprevir Combination, With or Without Ribavirin, for Treatment-Experienced Patients With Chronic Hepatitis C Infection
- (2017) Paul Kwo et al. GASTROENTEROLOGY
- Efficacy of 12 or 18 weeks of elbasvir plus grazoprevir with ribavirin in treatment-naïve, noncirrhotic HCV genotype 3-infected patients
- (2017) E. Gane et al. JOURNAL OF VIRAL HEPATITIS
- Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection
- (2017) Marc Bourlière et al. NEW ENGLAND JOURNAL OF MEDICINE
- High Efficacy of ABT-493 and ABT-530 Treatment in Patients With HCV Genotype 1 or 3 Infection and Compensated Cirrhosis
- (2016) Edward Gane et al. GASTROENTEROLOGY
- Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Hepatitis C Virus Genotype 2, 3, 4, or 6 Infections in an Open-Label, Phase 2 Trial
- (2016) Edward J. Gane et al. GASTROENTEROLOGY
- Short-duration treatment with elbasvir/grazoprevir and sofosbuvir for hepatitis C: A randomized trial
- (2016) Eric Lawitz et al. HEPATOLOGY
- Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY-3+)
- (2016) Vincent Leroy et al. HEPATOLOGY
- Grazoprevir–Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection
- (2015) Stefan Zeuzem et al. ANNALS OF INTERNAL MEDICINE
- Efficacy of Sofosbuvir Plus Ribavirin With or Without Peginterferon-Alfa in Patients With Hepatitis C Virus Genotype 3 Infection and Treatment-Experienced Patients With Cirrhosis and Hepatitis C Virus Genotype 2 Infection
- (2015) Graham R. Foster et al. GASTROENTEROLOGY
- Hepatitis C Virus
- (2015) Javier Ampuero et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study
- (2015) David R. Nelson et al. HEPATOLOGY
- Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study
- (2015) David Roth et al. LANCET
- Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)
- (2015) Marc Bourlière et al. LANCET INFECTIOUS DISEASES
- Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection
- (2015) Graham R. Foster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial
- (2015) Jürgen K Rockstroh et al. Lancet HIV
- Global epidemiology and genotype distribution of the hepatitis C virus infection
- (2014) Erin Gower et al. JOURNAL OF HEPATOLOGY
- Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection
- (2014) Nezam Afdhal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study
- (2013) Pilar Gayoso-Diz et al. BMC Endocrine Disorders
- Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3
- (2011) Alexander J Thompson et al. GUT
- Insulin Resistance Among Patients With Chronic Hepatitis C: Etiology and Impact on Treatment
- (2008) S HARRISON Clinical Gastroenterology and Hepatology
- Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C
- (2008) Ian Homer Y. Cua et al. HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now